Information
-
Trademark
-
90579137
-
International Classifications
-
Filing Date
March 15, 2021
3 years ago
-
Transaction Date
October 17, 2024
3 months ago
-
Status Date
October 16, 2024
3 months ago
-
Published for Opposition Date
May 17, 2022
2 years ago
-
Location Date
July 12, 2022
2 years ago
-
Status Code
734
-
Current Location
INTENT TO USE SECTION
Employee Name
WATSON, JULIE
-
Attorney Docket Number
752788
Attorney Name
Claudia W. Stangle
Law Office Assigned Location Code
L90
-
Owners
Mark Drawing Code
4
Mark Identification
ISARNA THERAPEUTICS
Case File Statements
- GS0051: Pharmaceutical and veterinary preparations for the treatment of tumors, pain, neurological diseases, liver disease, ophthalmologic diseases, pulmonary disease, renal diseases, and any other disease that is associated with the biologic action of Transforming Growth Factor beta (TGF-b) of the human body or of animals; sanitary preparations for medical purposes; liquids, solutions or active agents for use in the pharmaceutical and veterinary field, namely, for the treatment of tumors, pain, neurological diseases, liver disease, ophthalmologic diseases, pulmonary disease, renal diseases, and any other disease that is associated with the biologic action of Transforming Growth Factor beta (TGF-b) of the human body or of animals
- GS0441: Medical services in the pharmaceutical field, namely, the treatment of tumors, pain, neurological diseases and similar malfunctioning of the human body; veterinary services in the field of the treatment of tumors, pain, neurological diseases and similar malfunctioning of animals; hygienic and beauty care for human beings or animals, using liquids, solutions or active agents in the cosmetic field, namely, the plastic surgery and anaplastic field or anti-aging treatment
- DS0000: "THERAPEUTICS"
- GS0421: Scientific and technological services, namely, research and design relating thereto in the pharmaceutical and veterinary field, namely, for the treatment of tumors, pain, neurological diseases and similar malfunctioning of the human body or of animals; industrial analysis in the nature of testing pharmaceuticals to ensure compliance with industry standards; providing scientific research services in the fields of medicine, namely, research on tumor treatment, pain, neurological diseases and similar malfunctioning of the human body or of animals; design and development of computer hardware and software in the pharmaceutical and veterinary field, namely, for the treatment of tumors, pain, neurological diseases and similar malfunctioning of the human body or of animals
Case File Event Statements
-
10/14/2021 - 3 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
3/18/2021 - 3 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
6/14/2021 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
10/14/2021 - 3 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
10/14/2021 - 3 years ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
10/14/2021 - 3 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
4/11/2022 - 2 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
4/11/2022 - 2 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
4/11/2022 - 2 years ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
4/11/2022 - 2 years ago
10 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
4/13/2022 - 2 years ago
11 - ASSIGNED TO LIE
Type: ALIE
-
4/13/2022 - 2 years ago
12 - LAW OFFICE PUBLICATION REVIEW COMPLETED
Type: PREV
-
4/27/2022 - 2 years ago
13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
5/17/2022 - 2 years ago
14 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
5/17/2022 - 2 years ago
15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
7/12/2022 - 2 years ago
16 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Type: NOAM
-
12/8/2022 - 2 years ago
17 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
12/8/2022 - 2 years ago
18 - SOU EXTENSION 1 FILED
Type: EXT1
-
12/8/2022 - 2 years ago
19 - SOU EXTENSION 1 GRANTED
Type: EX1G
-
12/10/2022 - 2 years ago
20 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
6/14/2023 - a year ago
21 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
6/14/2023 - a year ago
22 - SOU EXTENSION 2 FILED
Type: EXT2
-
6/14/2023 - a year ago
23 - SOU EXTENSION 2 GRANTED
Type: EX2G
-
6/16/2023 - a year ago
24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
12/12/2023 - a year ago
25 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
12/12/2023 - a year ago
27 - SOU EXTENSION 3 GRANTED
Type: EX3G
-
12/12/2023 - a year ago
26 - SOU EXTENSION 3 FILED
Type: EXT3
-
6/17/2024 - 7 months ago
29 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
10/16/2024 - 3 months ago
33 - SOU TEAS EXTENSION RECEIVED
Type: EEXT
-
10/16/2024 - 3 months ago
36 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
10/16/2024 - 3 months ago
34 - SOU EXTENSION 5 FILED
Type: EXT5
-
10/16/2024 - 3 months ago
35 - SOU EXTENSION 5 GRANTED
Type: EX5G
-
12/14/2023 - a year ago
28 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
6/17/2024 - 7 months ago
32 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Type: EXRA
-
6/17/2024 - 7 months ago
30 - SOU EXTENSION 4 FILED
Type: EXT4
-
6/17/2024 - 7 months ago
31 - SOU EXTENSION 4 GRANTED
Type: EX4G